Status:
UNKNOWN
Mechanisms of COPD Exacerbation Recurrence
Lead Sponsor:
University College, London
Conditions:
Pulmonary Disease, Chronic Obstructive
COPD Exacerbation
Eligibility:
All Genders
18+ years
Brief Summary
Chronic obstructive pulmonary disease (COPD) is a common smoking-related lung disease. Patients with COPD are at increased risk of readmission to hospitals within the following 30 days. Hospital readm...
Eligibility Criteria
Inclusion
- Patients who have a primary diagnosis of COPD
- Patients admitted to hospital with an exacerbation.
Exclusion
- Patients in whom an initial diagnosis of an AECOPD is revised to an alternative at a later phase of the study.
- Patients who have a predominant history of asthma
- Patients with a confirmed active malignancy
- Patients who have a predominant history of bronchiectasis.
- Cognitive impairment patients with a Mental Test Score (MTS) of 6 or less.
- Inability to give informed consent to take part in the study
Key Trial Info
Start Date :
June 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
166 Patients enrolled
Trial Details
Trial ID
NCT04024735
Start Date
June 1 2019
End Date
May 1 2022
Last Update
July 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Free Hospital NHS
London, United Kingdom, NW3 2PF